United States· US:24689-792_2d125642-5083-4147-e063-6394a90a329c
Terazosin Hydrochloride
A terazosin product containing terazosin hydrochloride, registered in United States by Apnar Pharma LP. The same ATC class is registered in 12 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Terazosin is registered in 12 of 19 countries.
Countries holding a registration under ATC G04CA03 (terazosin), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 7 of them publish a price we can compare per daily dose
Terazosin · ATC G04CA03
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of terazosin costs, country by country.
Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.19 in United States to $0.93 in Switzerland — a ×5.0 gap.
- United States: $0.19 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Terazosin · price per daily dose (5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.93
- IT Italy$0.31
- US United States$0.19 (acquisition cost)
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Terazosin Hydrochloride
- Manufacturer
- Apnar Pharma LP
- Country
- United States (US)
- ATC code
- G04CA03
- ATC class
- Terazosin
- Defined daily dose
- 5 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 12, 2026
Packs & prices · 3
- ndc112468979201100 CAPSULE in 1 BOTTLE (24689-792-01)
- ndc11246897920390 CAPSULE in 1 BOTTLE (24689-792-03)
- ndc1124689792101000 CAPSULE in 1 BOTTLE (24689-792-10)
Regulatory notes
Interactions
186 interactions on record for terazosin.
Graded by severity as the source publishes them — 72 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Terazosin · interactions on record
186 records
- 72 moderate
- 1 minor
- 112 info
Most severe, free to view
- ThiethylperazinA04AB03moderate
- DiphenhydraminA04AB05moderate
- DronabinolA04AD10moderate
- NabiloneA04AD11moderate
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Terazosin in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBenph 2mg tabletsViatris UK Healthcare Ltd
- ItalyITRINEBERLIFE FARMACEUTICI S.P.A.
- BelgiumHytrin 1 mgAmdipharm
- SpainALFAPROST 5 mg COMPRIMIDOSBiowise Pharmaceuticals, S.L.
- CanadaAPO-TERAZOSINAPOTEX INC
- NetherlandsHytrin 10, tabletten 10 mgAmdipharm Limited
- FranceDYSALFA 1 mg, compriméAMDIPHARM
- NorwayHeitrinAmdipharm
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Uroflo, Vicard
- Belgium · Hytrin, Terazosab
- Czechia · Kornam
- Germany · Heitrin, Tera Tad
- Denmark · Sinalfa
- Spain · Alfaprost, Mayul
- France · Dysalfa, Hytrine
- United Kingdom (Northern Ireland) · Hytrin, Terazosin
- Greece · Hytrin
- Hungary · Setegis
- Ireland · Hytrin
- Italy · Itrin, Prostatil
- Luxembourg · Hytrin, Terazosab
- Netherlands · Hytrin, Terazosine Accord
- Norway · Sinalfa
- Poland · Hytrin, Kornam
- Portugal · Hytrin
- Sweden · Sinalfa
- Slovenia · Kornam
- Slovakia · Kornam
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/abe225ff-eddc-4bb8-ae9b-9ecf6ec0baf5 GET /v1/drugs/abe225ff-eddc-4bb8-ae9b-9ecf6ec0baf5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "D32S14F082",
"rxcui": "235224",
"inchikey": "NZMOFYDMGFQZLS-UHFFFAOYSA-N",
"display_name": "TERAZOSIN HYDROCHLORIDE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"livertox": {
"summary": null,
"livertox_id": null,
"hepatotoxicity_score": 5
},
"spl_meta": {
"b77a4a38-edb1-412e-97af-d49e862b32c1": {
"match": "brand_token",
"title": "TERAZOSIN CAPSULE [BRYANT RANCH PREPACK]",
"spl_version": "1",
"published_date": "2026-05-25"
}
},
"productid": "24689-792_2d125642-5083-4147-e063-6394a90a329c",
"productndc": "24689-792",
"dosage_form": "CAPSULE",
"orange_book": {
"appl_no": "074823",
"products": [
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "EQ 1MG BASE",
"product_no": "001",
"approval_date": "Mar 30, 1998"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "EQ 2MG BASE",
"product_no": "002",
"approval_date": "Mar 30, 1998"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "EQ 5MG BASE",
"product_no": "003",
"approval_date": "Mar 30, 1998"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "EQ 10MG BASE",
"product_no": "004",
"approval_date": "Mar 30, 1998"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "TERAZOSIN HYDROCHLORIDE",
"proprietary_name": "Terazosin Hydrochloride",
"active_ingred_unit": "mg/1",
"application_number": "ANDA074823",
"marketing_category": "ANDA",
"nonproprietary_name": "Terazosin Hydrochloride",
"start_marketing_date": "20200630",
"active_numerator_strength": "1"
}See everything about terazosin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.